← All trials
NCT04920773
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 3, 2021
- Primary completion
- May 21, 2021
- Completion date
- Jun 6, 2021
- First posted
- Jun 10, 2021
- Last posted
- Jun 10, 2021
- Enrollment
- 216
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- NMP Medical Research InstituteLead sponsor
- NMP Medical Research InstituteStudy director
- NMP Medical Research InstituteOverall official - principal investigator
- Aarogyam UKStudy chair
- Aarogyam UKCollaborator
- Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved UniversityStudy director
- Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved UniversityCollaborator
- Niramaya clinic, IndiaStudy chair
- Padmanabhama Ayurveda Hospital and Research CentreCollaborator
- Samta Ayurveda Prakoshtha, IndiaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.